EYE National Vision Holdings, Inc.
National Vision Holdings, Inc. (EYE) is a healthcare company in the Ophthalmic Goods industry, with a market capitalization of $1.3 billion. Shares last traded at $16.77, 44.1% below their 52-week high. Over the past year the stock is down 25.0%. EYE trades at a price-to-earnings ratio of 45.40, in line with the Ophthalmic Goods median of 45.40. Net profit margin is 1.5%, above the peer median of 0.8%. Revenue grew 9.0% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-01-03 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $0.38 | 2026-05-14 |
| FY 2025 | $0.37 | 2026-03-04 |
| Q3 2025 | $0.33 | 2025-11-06 |
| Q2 2025 | $0.29 | 2025-08-07 |
| Q1 2026 | $0.18 | 2026-05-14 |
| FY 2025 | $-0.36 | 2026-03-04 |
Ophthalmic Goods peers
EYE vs 9 industry peers (Ophthalmic Goods), by market cap.
| COO | Cooper Companies (The) | $12.9B | 34.36 | 3.15 | 9.2% | +1.51% |
| BLCO | Bausch & Lomb Corp | $5.3B | — | — | — | +0.07% |
| WRBY | Warby Parker Inc. | $3.2B | 1950.86 | 3.67 | 0.2% | +7.13% |
| STAA | Staar Surgical Co | $1.4B | -18.02 | 6.05 | -33.6% | -0.22% |
| EYE | National Vision Holdings, Inc. | $1.3B | 45.40 | 0.68 | 1.5% | +2.98% |
| RXST | Rxsight, Inc. | $195M | -5006967.75 | 1.45 | -0.0% | +2.51% |
| LUCY | Innovative Eyewear Inc | $5M | — | — | — | -3.39% |
| ALC | Alcon Inc | — | — | — | 30.8% | +0.87% |
| LUCYW | Innovative Eyewear Inc | — | — | — | — | -28.13% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.